Is there a best strategy for drug discovery? - SMR meeting

被引:0
|
作者
Lunec, A [1 ]
机构
[1] Thomson Current Drugs, London W1T 4LB, England
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This gathering of members from academia and industry allowed the sharing of ideas and techniques for the acceleration of drug discovery, and it was clear that there is a need for a more streamlined approach to discovery and development. Clearly, new technologies will aid in the discovery process, but the abilities of the human brain to analyze and interpret data should not be overlooked, as many discoveries have been made by chance or as the result of a hunch, and it would be a shame if the advent of artificial intelligence quashed that inquisitive aspect of drug discovery.
引用
收藏
页码:454 / 457
页数:4
相关论文
共 50 条
  • [1] Chemokine receptors and drug discovery - SMR meeting - 11 March 2004, Horsham, UK
    Bhalay, G
    Dunstan, A
    IDRUGS, 2004, 7 (05) : 441 - 443
  • [2] Meeting Report: Aging Research and Drug Discovery
    Meron, Esther
    Thaysen, Maria
    Angeli, Suzanne
    Antebi, Adam
    Barzilai, Nir
    Baur, Joseph A.
    Bekker-Jensen, Simon
    Birkisdottir, Maria
    Bischof, Evelyne
    Bruening, Jens
    Brunet, Anne
    Buchwalter, Abigail
    Cabreiro, Filipe
    Cai, Shiqing
    Chen, Brian H.
    Ermolaeva, Maria
    Ewald, Collin Y.
    Ferrucci, Luigi
    Florian, Maria Carolina
    Fortney, Kristen
    Freund, Adam
    Georgievskaya, Anastasia
    Gladyshev, Vadim N.
    Glass, David
    Golato, Tyler
    Gorbunova, Vera
    Hoejimakers, Jan
    Houtkooper, Riekelt H.
    Jager, Sibylle
    Jaksch, Frank
    Janssens, Georges
    Jensen, Martin Borch
    Kaeberlein, Matt
    Karsenty, Gerard
    de Keizer, Peter
    Kennedy, Brian
    Kirkland, James L.
    Kjaer, Michael
    Kroemer, Guido
    Lee, Kai-Fu
    Lemaitre, Jean-Marc
    Liaskos, David
    Longo, Valter D.
    Lu, Yu-Xuan
    MacArthur, Michael R.
    Maier, Andrea B.
    Manakanatas, Christina
    Mitchell, Sarah J.
    Moskalev, Alexey
    Niedernhofer, Laura
    AGING-US, 2022, 14 (02): : 530 - 543
  • [3] MEETING THE CHALLENGE OF CARDIOVASCULAR NEW DRUG DISCOVERY
    SMITH, RD
    DRUG DEVELOPMENT RESEARCH, 1984, 4 (03) : 237 - 240
  • [4] Drug discovery strategy for permeability assesment
    Declèves, X
    Bert, L
    Bogler, S
    Vayer, P
    Bertrand, M
    DRUG METABOLISM REVIEWS, 2002, 34 : 198 - 198
  • [6] Best in class computational drug discovery platform by integration
    Gobbi, Alberto
    Lee, Man-Ling
    Sellers, Benjamin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [7] Drug discovery tool pipeline - the best of all worlds
    Detering, Carsten
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [8] Meeting the unique challenges of drug discovery for neurodegenerative diseases
    Diana W Shineman
    Howard M Fillit
    BMC Neurology, 9 (Suppl 1)
  • [9] Fumigation in Ayurveda: Potential strategy for drug discovery and drug delivery
    Vishnuprasad, Chethala N.
    Pradeep, Nediyamparambu Sukumaran
    Cho, Yong Woo
    Gangadharan, Geethalayam Gopinathan
    Han, Sung Soo
    JOURNAL OF ETHNOPHARMACOLOGY, 2013, 149 (02) : 409 - 415
  • [10] Drug repurposing: An effective strategy to accelerate contemporary drug discovery
    Zhan, Peng
    Yu, Bin
    Ouyang, Liang
    DRUG DISCOVERY TODAY, 2022, 27 (07) : 1785 - 1788